Arcus Biosciences (RCUS) Stock Research

Arcus Biosciences

· RCUS

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

3.266 B

-2.32%

Today

Mizuho biotech analysts hold an analyst/industry conference call

2:57 PM

Over a week ago

Arcus Biosciences to host investor event on casdatifan data

RCUS

Sep 22, 8:49 AM

Arcus Biosciences initiated with bullish view at TD Cowen, here's why

RCUS

Sep 16, 6:14 AM

Arcus Biosciences price target raised by $5 at Truist, here's why

RCUS

Sep 8, 6:59 AM

Arcus Biosciences price target raised by $1 at Morgan Stanley

RCUS

Aug 10, 8:20 AM

Arcus Biosciences price target raised by $8 at Goldman Sachs

RCUS

Aug 7, 6:26 AM

Arcus Biosciences price target raised by $2 at Wedbush, here's why

RCUS

Aug 6, 8:44 AM

Arcus Biosciences price target raised by $3 at Wells Fargo, here's why

RCUS

Aug 6, 6:40 AM

Arcus Biosciences reports Q2 EPS (72c), consensus (81c)

RCUS

Aug 5, 5:23 PM

Arcus Biosciences price target raised by $4 at BofA, here's why

RCUS

Aug 3, 10:59 AM

Arcus Biosciences announces clinical supply pact with AVEO Oncology

RCUS

Jul 22, 4:36 PM

Arcus, Summit enter into clinical trial collaboration over kidney cancer

Jul 22, 4:35 PM

Arcus Biosciences price target raised by $13 at H.C. Wainwright, here's why

RCUS

Jul 20, 6:04 AM

Arcus Biosciences announces publication on ARC-20 study research

RCUS

Jul 1, 11:06 AM

Arcus Biosciences initiated with bullish view at LifeSci Capital

RCUS

Jun 4, 6:36 AM

Arcus enters clinical trial collaboration, supply agreement with Bristol Myers

Jun 3, 8:03 AM

Arcus Biosciences assumed with a Buy at Truist

RCUS

May 18, 6:32 AM

Arcus Biosciences price target raised by $2 at Morgan Stanley

RCUS

May 11, 8:15 AM

Arcus Biosciences reports Q1 EPS ($1.02), consensus (83c)

RCUS

May 5, 5:02 PM

Arcus Biosciences rises 12.2%

RCUS

Apr 22, 10:01 AM

Merck study miss not a read for Arcus, says H.C. Wainwright

Apr 21, 11:17 AM

Merck setback has positives and negatives for Arcus Biosciences, says BofA

Apr 21, 10:56 AM

Arcus Biosciences discontinues Star-121 study with Gilead due to futility

Apr 20, 3:00 PM

Arcus Biosciences price target lowered by $2 at Leerink, here's why

Apr 20, 2:51 PM

Wedbush raises Arcus Biosciences price target to $41, adds to Best Ideas List

RCUS

Apr 2, 9:06 AM

Charts